Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Xubo Gong"'
Autor:
Yi Zhang, Miso Park, Lucy Y. Ghoda, Dandan Zhao, Melissa Valerio, Ebtesam Nafie, Asaul Gonzalez, Kevin Ly, Bea Parcutela, Hyeran Choi, Xubo Gong, Fang Chen, Kaito Harada, Zhenhua Chen, Le Xuan Truong Nguyen, Flavia Pichiorri, Jianjun Chen, Joo Song, Stephen J. Forman, Idoroenyi Amanam, Bin Zhang, Jie Jin, John C. Williams, Guido Marcucci
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-18 (2024)
Abstract Background The interleukin-1 receptor accessory protein (IL1RAP) is highly expressed on acute myeloid leukemia (AML) bulk blasts and leukemic stem cells (LSCs), but not on normal hematopoietic stem cells (HSCs), providing an opportunity to t
Externí odkaz:
https://doaj.org/article/81c6c4a1c88f4c5d9d2eee24813cc8c0
Autor:
Xubo Gong, Lianjun Zhang, Xin He, Jing Yang, Xiang Li, Weiwei Liu, Bin Zhang, Zhihua Tao, Wenbin Qian
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract Natural killer (NK) cell-based therapies have made great progress in treating both hematological and solid tumors. Their unique mechanism of action does not rely on antigen presentation to recognize and eliminate tumor cells, making them a p
Externí odkaz:
https://doaj.org/article/5aca4f5190264219b91e460327579337
Autor:
Xubo Gong, Xin He, Lin Wang, Teng Yu, Weiwei Liu, Huiying Xu, Lan Jin, Xiang Li, Bin Zhang, Zhihua Tao, Wenbin Qian
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-4 (2024)
Abstract Patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) often exhibit limited responses to traditional chemotherapy, resulting in poor prognosis. The combination of venetoclax (VEN) with hypomethylating agents has been establ
Externí odkaz:
https://doaj.org/article/d7b962c32d33430392972de756f9ddc6
Autor:
Xubo Gong, Yi Zhang, Xin He, Milad Moloudizargari, Teng Yu, Lin Wang, Weiwei Liu, Lan Jin, Huiying Xu, Yang Xu, Zhihua Tao, Wenbin Qian
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-4 (2023)
Abstract Venetoclax (VEN), the first selective Bcl-2 inhibitor, has shown efficacy and safety both as monotherapy and in combination with other agents in the treatment of newly diagnosed acute myeloid leukemia (AML), while its role in relapsed or ref
Externí odkaz:
https://doaj.org/article/68631ef78b8447bda55113a130c5156b
Autor:
Xubo Gong, Piaoping Kong, Teng Yu, Xibin Xiao, Lin Wang, Yiwen Sang, Xiang Li, Bin Zhang, Zhihua Tao, Weiwei Liu
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-5 (2022)
Abstract Acute promyelocytic leukemia (APL) is highly aggressive and is frequently associated with disseminated intravascular coagulation and high early death rates. Although all-trans retinoic acid (RA) induces complete remission in a high proportio
Externí odkaz:
https://doaj.org/article/42f0fb2c1057413fa33187f7eb2699b5
Publikováno v:
Oncology Letters. Nov2020, Vol. 20 Issue 5, p1-10. 10p.
Autor:
Haifeng Ge, Donghua Gong, Xingguo Lu, Xiaoying Zhao, Teng Yu, Hongxiang Tu, Yongze Zhu, Yanbiao Fu, Jie Wu, Xubo Gong, Qiusu Tang
Publikováno v:
International Journal of Laboratory Hematology. 41:380-386
Introduction AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2) [inv(3)/t(3;3)] was very rare. Currently, most reports of AML-inv(3)/t(3;3) were from Western countries, and few reports were from Asian countries. Racial differences in patients with AM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5c031ad4064805c242bef0ef7ad69c
https://doi.org/10.1111/ijlh.12987
https://doi.org/10.1111/ijlh.12987
Autor:
Lin Wang, Lijuan Yan, Yanbiao Fu, Xibin Xiao, Bailai Hu, xubo gong, Sijia Shao, Xiao-ying Zhao
Background: Lymphoid neoplasms in serous effusions (SEs) were uncommon. Currently, most reports of lymphoid neoplasms in SEs were from Western countries, but few reports were from China, and the details were still unclear. Methods: Between January 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dac88c3c7fed766a5c0199abfc27722
https://doi.org/10.21203/rs.2.23380/v1
https://doi.org/10.21203/rs.2.23380/v1
Publikováno v:
Oncology Letters
Linalool can inhibit the malignant proliferation of numerous human malignant solid tumors, including hepatocellular carcinoma, breast cancer, small cell carcinoma and malignant melanoma. However, the role of linalool in T cell acute lymphoblastic leu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efcdfa8cceda42e2442961f93be62ae8
https://doi.org/10.3892/ol.2020.12042
https://doi.org/10.3892/ol.2020.12042